ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year... ( RANCHO CORDOVA Calif. Feb. 6 /- T...)

ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year

Date:2/6/2008

RANCHO CORDOVA, Calif., Feb. 6 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. (Nasdaq: KOOL), a leading supplier of innovative products and services that process and store adult stem cells for treatment of disease and injury, today reported results for the second quarter and first six months of fiscal 2008.

Revenues for the quarter ended December 31, 2007, were $5.5 million. This compares with revenues of $3.7 million for the second quarter of fiscal 2007 and $3.6 million for the first quarter of fiscal 2008. Total disposable revenues were $2.6 million, a 44 percent increase over disposable revenues of $1.8 million in the second quarter a year ago.

The Company reported a net loss of $1.7 million, or $0.03 per share, in the second quarter of fiscal 2008, versus a loss of $2.0 million, or $0.04 per share, in the second quarter a year ago. At December 31, 2007, ThermoGenesis had $30.5 million in cash, cash equivalents and short-term investments. Total cancellable backlog at the end of the second fiscal quarter was $3.9 million, a 50 percent increase over the $2.6 million in cancellable backlog a year ago.

"As we discussed in our January 10th update news release, the primary growth drivers during the quarter were increased AXP(TM) AutoXpress Platform (AXP) bag set shipments, improved BioArchive(R) System sales and growth in CryoSeal(R) FS System and disposable sales," noted Dr. William Osgood, the Company's Chief Executive Officer.

Osgood said the Company's results reflect its success in addressing AXP bag set production quality. In addition, the Company shipped 8 BioArchive devices during the quarter which compares to 3 devices shipped in the prior year same quarter, bringing the total number of installed BioArchiv
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8
Related biology technology :

1. ThermoGenesis Corp. to Announce Fourth Quarter and Year End Results for Fiscal Year 2007 on September 12, 2007
2. ThermoGenesis Corp. Reports Fourth Quarter and Fiscal Year 2007 Results
3. ThermoGenesis Corp. to Present at 2007 Global Life Sciences Conference on Thursday, September 27, 2007
4. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
5. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
6. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
7. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
8. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
9. CellCyte Genetics Corp. Forms Device Division to Develop and Manufacture Stem Cell Cultivation and Replication Products
10. Helix BioPharma Corp. announces fiscal 2007 results
11. Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington

Post Your Comments:

(Date:10/13/2008)..., Oct. 13 /PRNewswire-USNewswire/ -- Midwest Resea...of a new Center for,Integrated Algal Research and ...irector of Energy Programs., "Reducing America,s ...foremost challenges -- one in which MRI has been i...velopment and as the Management and Operating,cont...

(Date:10/13/2008)... /- Larry Corey, M.D., senior vice,pr...ous Disease Institute,at Fred Hutchinson Cancer Re...mbers of the prestigious Institutes of Medicine (I...e highest honors in the,fields of health and medic...ed outstanding professional achievement and commit...

(Date:10/13/2008)...en, October 13 /- Mentice, a leading,...unces the appointment of,Mr. Bjorn Larsson as Vice...oday Mr. Bjorn Larsson will head up and coordinate...rporate standpoint., Mr. Larsson brings to Mentic...keting and product management within pharmaceutica...

(Date:10/13/2008)...Oct. 13 /- Proteon Therapeutics is,pr...preclinical,demonstration of the potential of PRT-... lower limb peripheral arterial disease (PAD). The...Elastase Therapy: A Novel,Approach to Vessel Dilat...ual Transcatheter Cardiovascular Therapeutics (TCT...

Breaking Biology Technology:MRI Expands Energy Role: Launches Center for Integrated Algal Research and Creates Director of Energy Programs Position 2 Mentice Appoints Bjorn Larsson as Vice President of Global Marketing 2 Proteon Therapeutics to Present New Data on PRT-201 at Transcatheter Cardiovascular Therapeutics (TCT) Annual Symposium in Washington, D.C., October 13, 2008 2

[0] MRI Expands Energy Role: Launches Center for Integrated Algal Research and Creates Director of Energy Programs Position [0] Dr. Larry Corey Named New Member of the Institutes of Medicine [0] Mentice Appoints Bjorn Larsson as Vice President of Global Marketing [0] Proteon Therapeutics to Present New Data on PRT-201 at Transcatheter Cardiovascular Therapeutics (TCT) Annual Symposium in Washington, D.C., October 13, 2008

... ,>O. Rönn 1 , M. Landström 2 , A. Edm... 1 GE Healthcare, Uppsala, Sweden , ... Sweden , , ECL Plex™ Weste...t picogram levels, with linearity over 3.6 orders ...neously, and differential quantitation of low-abun...

...Introduction , High-throughput screening f...g development and a key application is in the area...upled receptors (GPCRs) (1). , <P ,>It i...han GPCRs of potential therapeutic value requiring...The Sigma-RBI Library of Pharmacologically Active ...

... 77, TE 70 PWR, TE 77 PWR , ECL™ Sem... electrophoretic transfer results using low curren..., • Units available with and withou...ity , • Complete, uniform electr...less than 1 h , • Minimal buffe...

... Key words: adenoviral vector • viral ...bull; gene delivery, , Biological ... greatly aid secondary screening as well as lead a...ts several challenges. Establishing stable cell sy...table levels is time-consuming. In addition, cellu...

Detection and quantitation of low-abundant proteins with ECL Plex fluorescent Western blotting Screening for β2-adrenergic receptor agonists using the pH-sensitive dye,CypHer5, and the IN Cell Analyzer 3000 ECL Semi-dry Blotters Performance of Ad-A-Gene EGFP-MAPKAP-k2: an adenoviral vector gene delivery system

(Date:10/13/2008)...syth Institute, working with collaborators at Tuft...w control over embryonic stem cells, behavior. The...hanism within frog embryonic stem cells and trigge... growth, change in cell shape, and invasion of the...rical signals are a powerful control mechanism tha...

(Date:10/13/2008)...African chimpanzees living in Cte d,Ivoire, resear... dropped in numbers by a whopping 90 percent since...ew remaining chimpanzees are now highly fragmented...ional Park, according to a report in the October 1...cation. , This alarming decline in a country tha...

(Date:10/13/2008)...y different parts of the brain can come under atta...ding to a new study in mice with an MS-like diseas...nvading T cells dictates whether it,s the spinal c...from researchers at the University of Maryland Sch...sity in St. Louiswill be published online on Octob...

(Date:10/12/2008)...e in French . , Researchers at McGill Univers.... have identified two genetic variants in caucasia...ncrease the risk of male pattern baldness. Their r...ature Genetics. , About a third of all men are ...ondition,s social and economic impact is considera...

[0] Forsyth scientists trigger cancer-like response from embryonic stem cells [0] In a last 'stronghold' for endangered chimpanzees, survey finds drastic decline [0] Response to immune protein determines pathology of multiple sclerosis [0] Researchers discover baldness gene: 1 in 7 men at risk

... Medical Center implanted Artificial Silicon Retin... treat vision loss caused by retinitis pigmentosa ...ameter and one-thousandth of an inch thick, less t...s had surgery Tuesday, January 25. The fifth patie... investigator Dr. John Pollack performed the surge...

...bright, light-emitting molecules have enabled rese...ter below the skin surface using only infrared lig...esearchers based at the University of Pennsylvania...scent materials called porphyrins within the surfa... a tumor within a living rodent. Their findings, w...

... to humane alternatives to the use of animals in r...wn that requires using animals as part of the test... Committee for Responsible Medicine, you invent yo... announced today that PCRM has developed the world...o measure insulin levels in individuals with diabe...

...searchers have identified several genetic changes ... help researchers better understand how and why pe...sue of the Journal of Neuroscience, researchers re...ion patterns regulated by alcohol in two mouse str...fer in a number of behavioral responses to acute a...

Other Biology News:Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss 2 Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss 3 Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin 2 PCRM develops world's first cruelty-free insulin assay 2 VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain 2 VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain 3

Ophthalmologists Use Artificial Silicon Retina Microchip To Treat Vision Loss Self-assembled nano-sized probes allow Penn researchers to see tumors through flesh and skin PCRM develops world's first cruelty-free insulin assay VCU Researchers Identify Networks Of Genes Responding To Alcohol In The Brain

Sterile, individually wrapped, 4mm Cuvettes

...an enhanced form of Tobacco Etch Virus (TEV) prote...nd significantly more stable than native TEV prote...se specifically recognizes a seven amino acid (Glu... Gly), making it useful for removing affinity tags...

... a fully flexible quadrupole MS detector optimized...peed HPLC, 1-D and 2-D LC, as well as capillary an... gas system to create a finer spray mist for high ... compounds, while providing for high reliability, ...

S-100A10 (H-80)

Biology Products:

Electroporation Cuvettes, 4 mm gap. 50 from Thermo Scientific AcTEV Protease from Invitrogen LCMS-2010EV from Shimadzu Biotech Rabbit Anti-S-100A10 (H-80) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.

ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year...( RANCHO CORDOVA Calif. Feb. 6 /- T...)